Ionis Pharmaceuticals, Inc. · 15 hours ago
Associate Director, IP Operations
Ionis Pharmaceuticals, Inc. is a pioneering company in RNA-targeted medicines, dedicated to transforming lives through innovative drug discovery. The Associate Director of IP Operations will build and maintain essential IP processes and workflows, oversee critical IP administrative functions, and ensure efficient operations to support the long-term evolution of the Ionis IP department.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Operationalize IP Strategy: develop and implement systems and processes that translate IP strategy into actionable operational plans, ensuring alignment with corporate and department objectives
Technology Integration and Vendor Oversight: identify, onboard, test, implement, and manage technology solutions and vendors that support IP operations (e.g., docketing, annuities, patent and trademark search and monitoring, legal research, discovery)
Data Management: establish and refine protocols for effective data collection, storage, and analysis for a large global IP estate, ensuring critical information is secure and appropriately accessible
Process Improvement: continuously assess and enhance IP processes and workflows relevant to patent and trademark prosecution, IP transactions, and IP contentious matters, using industry best practices to improve efficiency and minimize risk
Cross-Functional Collaboration: support and represent, as assigned, senior IP management on enterprise-wide functions such as budget, compliance, external publications, and stakeholder communication
Project Management: ensure department projects, initiatives, and workflows are appropriately resourced and executed on time within budget
Team Management: oversee the IP administrative team and related functions, providing guidance and support regardless of a direct supervisory role
Internal and External Engagement: organize and support events and team-building activities that promote collaboration and knowledge sharing with internal and external colleagues and stakeholders
Industry Knowledge: stay informed about industry best practices, trends, and developments to enhance operational effectiveness
Other duties as assigned
Qualification
Required
bachelor's degree is required, preferably in life sciences
5+ years of experience in IP operations or a related field
proven experience with technology implementation and integration
strong analytical and problem-solving abilities
exceptional interpersonal skills with the ability to collaborate effectively and communicate seamlessly with colleagues at all levels across the organization
excellent judgment and effective problem-solving skills, with the capacity to judicially escalate issues
professional, clear, and concise written and verbal communication skills required
high level of professionalism and discretion in all interactions
keen attention to detail and accuracy
ability to set and meet aggressive deadlines while staying organized
capable of appropriately prioritizing and managing multiple complex tasks to ensure timely project completion
proven experience in managing teams and fostering a collaborative work environment to achieve organizational goals
Preferred
a JD, MBA, and/or a graduate degree in life sciences is preferred
registration to practice before the USPTO is a plus
Benefits
Ionis offers an excellent benefits package!
Company
Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases.
H1B Sponsorship
Ionis Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (8)
2024 (5)
2023 (3)
2022 (5)
2021 (5)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$2.45B2025-11-13Post Ipo Debt· $700M
2024-09-09Post Ipo Equity· $500.3M
2023-06-06Post Ipo Debt· $500M
Leadership Team
Recent News
2026-01-08
Company data provided by crunchbase